Gold nanoparticles conjugated with resveratrol induce cell cycle arrest in MCF-7 cell lines
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Dong Gun | - |
dc.contributor.author | Go, Eun Byeol | - |
dc.contributor.author | Lee, Mindong | - |
dc.contributor.author | Pak, Pyo June | - |
dc.contributor.author | Kim, Joong-Su | - |
dc.contributor.author | Chung, Namhyun | - |
dc.date.accessioned | 2021-09-01T13:39:30Z | - |
dc.date.available | 2021-09-01T13:39:30Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2019-06-21 | - |
dc.identifier.issn | 2468-0834 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/64741 | - |
dc.description.abstract | Resveratrol is a kind of phytoalexin produced in several plants with self-defense effect. It is known for its anti-inflammatory and ant-cancer effects. However, it has low efficacy due to its degradation before reaching the target. To heighten its delivery rate and efficacy, gold nanoparticles (GNPs) under 30nm size were synthesized as drug carrier and conjugated with resveratrol via polyvinylpyrrolidone (PVP) as cross-linker. These gold nanoparticles conjugated with resveratrol (GRs) were used to estimate their anti-tumor effects through cell cycle arrest. It was found that resveratrol- and GRs-treated groups had decreased extent of G0/G1 phase but increased extent of S phase compared to control and GNP-treated groups, suggesting that the effect was due to resveratrol which was attached to gold nanoparticles. To estimate cytotoxicity after treatment with GNPs and GRs, the extent of lactate dehydrogenase (LDH) release was investigated. Results showed that GNPs and GRs-treated groups had almost no difference in LDH release compared to control group, suggesting that the extent of toxicity was not significant. Taken together, these results suggest that GRs could be potentially effective in treating cancer as anti-tumor drug with further development. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER SINGAPORE PTE LTD | - |
dc.subject | CANCER | - |
dc.subject | APOPTOSIS | - |
dc.subject | ANTIOXIDANT | - |
dc.subject | CURCUMIN | - |
dc.subject | IMPROVES | - |
dc.subject | GROWTH | - |
dc.title | Gold nanoparticles conjugated with resveratrol induce cell cycle arrest in MCF-7 cell lines | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Chung, Namhyun | - |
dc.identifier.doi | 10.1186/s13765-019-0440-6 | - |
dc.identifier.scopusid | 2-s2.0-85067878219 | - |
dc.identifier.wosid | 000472554600001 | - |
dc.identifier.bibliographicCitation | APPLIED BIOLOGICAL CHEMISTRY, v.62 | - |
dc.relation.isPartOf | APPLIED BIOLOGICAL CHEMISTRY | - |
dc.citation.title | APPLIED BIOLOGICAL CHEMISTRY | - |
dc.citation.volume | 62 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002474943 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Food Science & Technology | - |
dc.relation.journalWebOfScienceCategory | Food Science & Technology | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | APOPTOSIS | - |
dc.subject.keywordPlus | ANTIOXIDANT | - |
dc.subject.keywordPlus | CURCUMIN | - |
dc.subject.keywordPlus | IMPROVES | - |
dc.subject.keywordPlus | GROWTH | - |
dc.subject.keywordAuthor | Anti-tumor effects | - |
dc.subject.keywordAuthor | Cytotoxicity | - |
dc.subject.keywordAuthor | Gold nanoparticles | - |
dc.subject.keywordAuthor | MCF-7 | - |
dc.subject.keywordAuthor | Resveratrol | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.